Patent · US Active

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

US8101799B2 · kind B2 · utility

27Cited by

11References

77Claims

0Family size

Assignee

Ardea Biosciences, Inc · US

Inventors

Andreas Maderna · Stony Point, US
Jean-Michel Vernier · Laguna Niguel, US
Dinesh Barawkar · Lake Forest, US
Varaprasad Chamakura · Irvine, US
Hassan El Abdellaoui · Jamestown, US
Zhi Hong · Chapel Hill, US

Key dates

Filing date	Jul 30, 2007
Grant date	Jan 24, 2012
Priority date	—
Expiry date	Dec 13, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention concerns N—(2-arylamino) aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.